SCHEMBL18039043

SCHEMBL18039043

Nc1ncnc2c1ncn2[C@@H]1O[C@H]([C@H](O)c2ccc(F)c(F)c2)[C@H](O)[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 15/20 1.00
▸ WDR77 Q9BQA1 14/20 1.00
▸ AHCY P23526 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21413928 1.00 PRMT5 (1.00) PRMT5WDR77AHCY
SCHEMBL18009839 1.00 PRMT5 (1.00) PRMT5WDR77AHCY
SCHEMBL24625951 0.92 PRMT5 (0.84) PRMT5WDR77
SCHEMBL24478704 0.92 PRMT5 (0.84) PRMT5WDR77
SCHEMBL24625909 0.87 PRMT5 (0.77) PRMT5WDR77AHCY
SCHEMBL18026153 0.86 PRMT5 (0.76) PRMT5WDR77
SCHEMBL18026117 0.86 PRMT5 (0.76) PRMT5WDR77
SCHEMBL24146403 0.85 PRMT5 (0.75) PRMT5WDR77
SCHEMBL30128123 0.85 PRMT5 (0.75) PRMT5WDR77
SCHEMBL7732757 0.85 PRMT5 (0.74) PRMT5WDR77AHCY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3262057-B1 SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER (US) 2020-04-15 — — EP disclosed
EP-3262057-A1 SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS Pfizer Inc (US) 2018-01-03 — — EP disclosed
WO-2016135582-A1 SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER INC. (US) 2016-09-01 — — WO disclosed
Send feedback